Skip to main content
. 2023 Mar 30;21(4):223. doi: 10.3390/md21040223

Figure 5.

Figure 5

Anti-inflammatory assays of compounds 17. (a) Images of inflammatory sites in CuSO4-induced transgenic fluorescent zebrafish (Tg: zlyz-EGFP) expressing enhanced green fluorescent protein (EGFP) treated with compounds 17, using indomethacin as a positive control. (b) Quantitative analysis of macrophages in the region of inflammatory sites in zebrafish treated with compounds 17 at 20 μM. #### indicates that the CuSO4 model group has a very significant difference compared with the control group (p < 0.01). ** indicates that the sample groups have significant differences compared with the CuSO4 model group (p < 0.01).